Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1985 Mar;27(3):388–392. doi: 10.1128/aac.27.3.388

Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.

H Goossens, P De Mol, H Coignau, J Levy, O Grados, G Ghysels, H Innocent, J P Butzler
PMCID: PMC176282  PMID: 3158276

Abstract

The in vitro activity of drugs currently used in the treatment of diarrhea against 595 enteropathogens from worldwide sources was compared with that of six newly developed antibiotics, ciprofloxacin; norfloxacin; ofloxacin; aztreonam; HR810, an expanded-spectrum cephalosporin; and RU28965, a new macrolide. In contrast with ampicillin and chloramphenicol, trimethoprim-sulfamethoxazole showed an excellent activity against all of the enteropathogens tested, except Campylobacter species. Ciprofloxacin had the highest activity, with an overall 90% MIC of less than or equal to 0.097 micrograms/ml, except for Campylobacter species (0.39 micrograms/ml). Unlike other cephalosporins, HR810 showed a satisfactory activity against Campylobacter species (90% MIC of 3.12 micrograms/ml). RU28965 was three times less active than erythromycin against Campylobacter species.

Full text

PDF
390

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barlam T., Neu H. C. In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria. Antimicrob Agents Chemother. 1984 Apr;25(4):529–531. doi: 10.1128/aac.25.4.529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brumfitt W., Franklin I., Grady D., Hamilton-Miller J. M., Iliffe A. Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother. 1984 Nov;26(5):757–761. doi: 10.1128/aac.26.5.757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carlson J. R., Thornton S. A., DuPont H. L., West A. H., Mathewson J. J. Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens. Antimicrob Agents Chemother. 1983 Oct;24(4):509–513. doi: 10.1128/aac.24.4.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cherubin C. E. Antibiotic resistance of Salmonella in Europe and the United States. Rev Infect Dis. 1981 Nov-Dec;3(6):1105–1126. doi: 10.1093/clinids/3.6.1105. [DOI] [PubMed] [Google Scholar]
  5. De Mol P., Van Wijnendaele F., Hemelhof W., Corrazza Y. Possible field test for ST-producing Escherichia coli. Lancet. 1983 Mar 5;1(8323):524–525. doi: 10.1016/s0140-6736(83)92207-9. [DOI] [PubMed] [Google Scholar]
  6. Dornbusch K., Gezelius L. Susceptibility testing to trimethoprim alone and combined with sulphonamides. Chemotherapy. 1980;26(6):418–426. doi: 10.1159/000237937. [DOI] [PubMed] [Google Scholar]
  7. Giannella R. A. Suckling mouse model for detection of heat-stable Escherichia coli enterotoxin: characteristics of the model. Infect Immun. 1976 Jul;14(1):95–99. doi: 10.1128/iai.14.1.95-99.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goodman L. J., Fliegelman R. M., Trenholme G. M., Kaplan R. L. Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens. Antimicrob Agents Chemother. 1984 Apr;25(4):504–506. doi: 10.1128/aac.25.4.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Goossens H., De Boeck M., Butzler J. P. A new selective medium for the isolation of Campylobacter jejuni from human faeces. Eur J Clin Microbiol. 1983 Aug;2(4):389–393. doi: 10.1007/BF02019476. [DOI] [PubMed] [Google Scholar]
  10. Goossens H., Vanhoof R., De Mol P., Grados O., Ghysels G., Butzler J. P. In-vitro susceptibility of salmonellae to antimicrobial agents. J Antimicrob Chemother. 1984 Jun;13(6):559–565. doi: 10.1093/jac/13.6.559. [DOI] [PubMed] [Google Scholar]
  11. Goossens H., Vanhoof R., Grados O., Dekegel D., Butzler J. P. Ceftazidime activity on multiresistant salmonella. Lancet. 1982 Oct 2;2(8301):769–770. doi: 10.1016/s0140-6736(82)90952-7. [DOI] [PubMed] [Google Scholar]
  12. Jones R. N., Barry A. L., Thornsberry C. In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs. Antimicrob Agents Chemother. 1983 Aug;24(2):209–215. doi: 10.1128/aac.24.2.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jones R. N., Thornsberry C., Barry A. L. In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin. Antimicrob Agents Chemother. 1984 Jun;25(6):710–718. doi: 10.1128/aac.25.6.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lepage P., Bogaerts J., Nsengumuremyi F., Hitimana D. G., Van Goethem C., Vandepitte J., Butzler J. P. Severe multiresistant Salmonella typhimurium systemic infections in Central Africa--clinical features and treatment in a paediatric department. J Antimicrob Chemother. 1984 Sep;14 (Suppl B):153–159. doi: 10.1093/jac/14.suppl_b.153. [DOI] [PubMed] [Google Scholar]
  15. Sack D. A., Sack R. B. Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture. Infect Immun. 1975 Feb;11(2):334–336. doi: 10.1128/iai.11.2.334-336.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Shungu D. L., Weinberg E., Gadebusch H. H. In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens. Antimicrob Agents Chemother. 1983 Jan;23(1):86–90. doi: 10.1128/aac.23.1.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Skirrow M. B., Benjamin J. Differentiation of enteropathogenic Campylobacter. J Clin Pathol. 1980 Nov;33(11):1122–1122. doi: 10.1136/jcp.33.11.1122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Vanhoof R., Goossens H., Coignau H., Stas G., Butzler J. P. Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents. Antimicrob Agents Chemother. 1982 Jun;21(6):990–992. doi: 10.1128/aac.21.6.990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Vanhoof R., Gordts B., Dierickx R., Coignau H., Butzler J. P. Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni. Antimicrob Agents Chemother. 1980 Jul;18(1):118–121. doi: 10.1128/aac.18.1.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. de Mol P., Brasseur D., Hemelhof W., Kalala T., Butzler J. P., Vis H. L. Enteropathogenic agents in children with diarrhoea in rural Zaire. Lancet. 1983 Mar 5;1(8323):516–518. doi: 10.1016/s0140-6736(83)92202-x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES